1 / 11

Reduction Of Surgical Site Infection using a Novel Intervention

ROSSINI ? Background. Surgical site infection (SSI) post-laparotomy Up to 15% of clean-contaminated surgery30-40% of ?dirty' operations? of post-operative deaths Additional cost ? up to ?6KWound-edge Protectors - not mentioned in NICE guidelines but 2 previous small RCTs showing favourable ou

delfina
Download Presentation

Reduction Of Surgical Site Infection using a Novel Intervention

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. Reduction Of Surgical Site Infection using a Novel Intervention

    2. ROSSINI – Background Surgical site infection (SSI) post-laparotomy Up to 15% of clean-contaminated surgery 30-40% of ‘dirty’ operations ? of post-operative deaths Additional cost – up to Ł6K Wound-edge Protectors - not mentioned in NICE guidelines but 2 previous small RCTs showing favourable outcome

    3. ROSSINI – Design West Midlands Research Collaborative Successful NIHR RfPB grant application for Ł250,000 Full time trials manager based at Birmingham Primary Care Trials Unit IRAS ethical approval granted 750 patients over 2 years at 22 sites

    4. Primary Hypothesis: Use of a wound-edge protection device in adults undergoing laparotomy will result in a reduced rate of surgical site infection (SSI) at 30 days.

    5. Secondary Objectives: To determine whether the efficacy of a wound-edge protection device in reducing SSI is associated with: 1) The degree of wound contamination (clean / clean / contaminated / contaminated / dirty) 2) Comorbidity (e.g. diabetes, smoking, obesity) 3) Duration of operation 4) Grade of surgeon closing wound And to assess if the use of a wound-edge protection device: 5) Improves health-related quality of life (QoL) 6) Reduces length of stay in hospital 7) Is cost-effective and safe

    6. Is the patient eligible? Inclusion criteria Over 18 Laparotomy via midline, transverse or Kocher’s/Rooftop Any surgical indication Emergency and Elective cases Exclusion criteria Unable to consent Laparoscopic assisted cases

    8. Follow-up plans Definition of SSI Using the internationally accepted ‘Centers for Disease Control’ guidelines Blinded wound reviews performed at 1) Day 5-7 2) Day 30-33 Using standardised wound assessment tool:

    9. Talk about pilot studyTalk about pilot study

    10. ROSSINI – Opening a Site

    11. Rossini Site Team Principle investigator - One Consultant 2x Registrars Research / Specialist Nurses All researchers will require Good Clinical Practice (GCP) training prior to consenting participants

    12. Website www.rossini.bham.ac.uk - Full study protocol - Link to randomiser - Instruction for surgeons - All 6 Case Report Form samples - Letter to GP, consent form etc

More Related